MedTrace Logo

MINGO Supplemental Trial in X-linked Dystonia-Parkinsonism Patients

NCT03019458 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-04-30

Study results available
· View outcomes & findings →

Summary

To see whether MINGO, a food supplement, will be able to lessen the drastic weight loss seen among X-linked Dystonia Parkinsonism patients.

Conditions

  • X-Linked Dystonia Parkinsonism

Interventions

DIETARY_SUPPLEMENT

MINGO

6 20oz sachets will be taken daily by intervention group

Sponsors & Collaborators

  • Jose R. Reyes Memorial Medical Center

    collaborator OTHER_GOV

  • Massachusetts General Hospital

    collaborator OTHER

  • Sunshine Care Foundation

    lead OTHER

Principal Investigators

  • Criscely L Go, MD,FPNA,DPBP · Jose R. Reyes Memorial Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-10
Primary Completion
2017-05-08
Completion
2017-06-26

Countries

  • Philippines

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03019458 on ClinicalTrials.gov